Lin Yu-ting cleared to return to women’s boxing competition

Olympic champion Lin Yu-ting has been cleared to compete in women’s boxing after World Boxing verified she met the organisation’s new qualification requirements. The 30-year-old Taiwanese pugilist, who secured women’s featherweight gold for Chinese Taipei at the 2024 Paris Olympics, had become embroiled in a high-profile eligibility dispute alongside Algeria’s Imane Khelif. Both boxers were formerly banned from the 2023 World Championships by the International Boxing Association, which cited non-compliance with female competition requirements. World Boxing, which assumed oversight of the sport at Olympic competition level after the IOC’s suspension of the IBA, introduced compulsory sex screening in August 2025. Lin’s clearance comes after a finished appeals procedure and health assessment by World Boxing’s independent experts.

The eligibility scandal that stirred up the Olympic boxing world

Lin Yu-ting’s clearance signals a significant turning point in one of Olympic sport’s most disputed eligibility disputes. The row broke out when the IBA disqualified both Lin and Khelif from the 2023 World Championship event, stating they had not satisfied the criteria for competing in women’s competitions. Notwithstanding this decision, Lin subsequently secure Olympic gold in Paris shortly afterwards, performing under IOC control after the sports body stripped the IBA of its status due to serious integrity and governance concerns. The incident exposed significant fractures within the boxing establishment and raised difficult questions about qualification testing and fairness in women’s sport.

The dispute amplified the oversight surrounding eligibility policies in female boxing at the elite echelons of competition. Lin’s withdrawal from numerous competitions following the governing body’s implementation of mandatory sex testing in August 2025 highlighted the ambiguity concerning her eligibility. The appeal process, whilst thorough and ultimately vindicated the athlete, underscored the psychological and career impact of prolonged eligibility questions. World Boxing’s commitment to establish independent medical review mechanisms signified an attempt to establish improved, more open protocols for the activity in future.

• IBA banned Lin and Khelif from the 2023 World Championships
• IOC removed IBA citing integrity and governance failures
• Lin secured Olympic gold despite eligibility concerns in Paris
• World Boxing introduced compulsory sex testing in August 2025

World Boxing’s updated testing protocol explained

World Boxing’s compulsory sex screening policy, established in August 2025, constitutes a significant change in how the sport handles eligibility verification. The updated system centres on a particular genetic examination intended to establish biological sex through scientific analysis, superseding the former approach that had sparked considerable debate. This method aims to provide objective, measurable criteria that World Boxing argues will protect both sporting integrity and competitor welfare. The policy covers all competitors in women’s divisions and includes a structured appeal process, enabling competitors to dispute initial findings with accompanying medical documentation. This structure is intended to create consistency and transparency across international boxing events.

The implementation of mandatory testing has demonstrated importance for athletes like Lin Yu-ting, who experienced prolonged ambiguity whilst the updated protocol was introduced. World Boxing’s decision to include an separate clinical assessment element indicates understanding of the complexity surrounding eligibility determinations. The appeal process allows athletes to provide detailed medical records for assessment by World Boxing’s Medical Committee, guaranteeing that individual circumstances get adequate attention. This fair-minded strategy attempts to combine scientific rigour with process equity, recognising that biological sex is not always straightforward. The organisation stresses that the policy’s core purpose is preserving fair competition whilst safeguarding competitor protections and dignity throughout the validation process.

How the SRY gene test operates

The SRY gene test operates by establishing the presence of a particular genetic marker that World Boxing identifies as an indicator of male biological sex. The test assesses genetic material to ascertain whether the Y chromosome is present, which typically characterises male development. According to World Boxing, this genetic marker delivers an scientifically measurable indicator that can guide eligibility decisions. The test constitutes a transition to scientific methodology in establishing sex determination, distinguishing itself from previous approaches that relied on different criteria. Results are evaluated by independent medical professionals who assess the findings in the wider clinical setting.

Athletes who test positive for the SRY gene are not automatically disqualified; instead, they proceed through an appeal process enabling them to submit additional medical evidence. World Boxing’s Medical Committee reviews all provided documentation thoroughly before determining final eligibility determinations. This appeals mechanism acknowledges that genetic testing by itself may not provide the full biological picture, especially for athletes with conditions impacting sex development. The review process considers clinical history, hormone levels, and other pertinent clinical factors alongside genetic results. This multi-faceted approach seeks to guarantee that determinations are scientifically valid and individually appropriate rather than based solely on single test results.

• Reveals Y chromosome presence indicating male sex determination
• Positive results trigger standalone clinical assessment appeal process
• Clinical Panel evaluates genetic and clinical data in detail

The appeal mechanism and medical evidence

Following an preliminary assessment in 2025, the Chinese Taipei Boxing Association initiated a official challenge on Lin’s behalf, providing comprehensive medical documentation to World Boxing for impartial examination. The appeal mechanism is a critical safeguard within World Boxing’s qualification requirements, allowing athletes to contest original screening outcomes by presenting relevant medical documentation. This mechanism recognises that sex classification is complex and that genetic markers alone do not provide the full picture of an person’s clinical background and biological makeup. The CTBA’s choice to advance the challenge demonstrated confidence in Lin’s case and dedication to clearing her name through proper channels.

The submission of medical documents represented a crucial turning point in the determination of Lin’s competitive standing. World Boxing’s medical specialists performed a comprehensive assessment of all evidence presented, considering not only genetic test results but also wider medical considerations including hormone levels, clinical background, and other relevant biological factors. This thorough methodology guaranteed that the determination was grounded in complete medical assessment rather than single test findings. The stringent examination procedure underscored World Boxing’s dedication to making decisions that are both scientifically sound and personally suitable, whilst maintaining the standards of women’s competition.

What the medical committee determined

The World Boxing Medical Committee established that Lin was female from birth and fulfilled all criteria for participation in the female category, with no performance advantage. This decision came after detailed review of the medical records and constituted a definitive resolution to the eligibility question that had overshadowed her career since the 2023 World Championships. The committee’s ruling affirmed Lin’s eligibility to compete at the highest levels of women’s boxing, removing barriers for her return to international competition.

What lies ahead for Lin and women’s boxing

Lin’s clearance constitutes a significant turning point not only for her career but for women’s boxing more broadly. The 30-year-old can now resume competing in World Boxing-sanctioned events after missing many events since the mandatory sex testing policy was introduced in August 2025. Her return represents a chance to reclaim her status as a two-time world champion and expand upon her Olympic gold medal from Paris. The resolution also delivers closure for the Chinese Taipei Boxing Association, which has firmly stood behind Lin throughout the disputed eligibility proceedings and marked the vindication of her status.

The case carries broader implications for how international sports bodies approach eligibility policies and athlete welfare. World Boxing’s choice to establish a thorough appeals mechanism with independent medical review sets a precedent for reconciling sporting fairness with individual fairness. As Lin prepares to return to the ring, her comeback will be closely watched by the boxing community and further afield, potentially influencing how other sports federations develop and refine their own eligibility frameworks. The pathway forward underscores the significance of thorough, transparent processes that honour both the scientific aspects of sex testing and the human dignity of athletes.

• Lin can now participate in all World Boxing-sanctioned global tournaments unrestricted.
• The appeals procedure demonstrates World Boxing’s pledge of fair, evidence-based eligibility decisions.
• Her comeback strengthens faith in women’s boxing oversight under this new regulatory structure.